02.25.15
Blue Belt Technologies Inc. is celebrating a milestone.
Officials for the Minneapolis, Minn.-based firm, which makes “smart” surgical instruments for use in orthopedic surgery, reported the 1,000th partial knee replacement procedure has been performed using the company’s Navio surgical system. Navio is the firm’s principal technology. The system uses computer navigation and handheld robotic-assisted technology to provide accurate and precise bone preparation for unicondylar and patellofemoral knee replacement procedures.
The case was performed by Michael Higgins, M.D., orthopedic surgeon at Sentera CarePlex Hospital in Hampton, Va. “Navio has had tremendous success in the last two years”
“The precision, ease of use and predictability of outcomes that Navio’s robotic-assistance offers have made partial knee replacements a true pleasure to perform,” said Higgins.
After receiving CE mark for the Navio system in February 2012 and U.S. Food and Drug Administration (FDA) clearance in December 2012, Blue Belt initiated a full rollout in March 2013. In 2014, Blue Belt Technologies achieved several commercial milestones including selling 33 Navio systems, partnering with two major implant companies, and receiving FDA clearance for a patellofemoral joint replacement application.
“Navio has had tremendous success in the last two years,” said Eric Timko, president and CEO of Blue Belt Technologies. “Last August, Blue Belt announced our 500th case. Six months later we’ve seen our incredible growth continue. Our company remains committed to bringing truly innovative technology to our customers and fostering the growth that happens when we do.”
The Navio system provides robotic assistance for partial knee replacement procedures through proprietary computed tomography-free navigation software and a handheld, computer-controlled, bone-shaping tool. Navio supports six different knee systems. In addition, the company’s Stride unicondylar knee system provides implant features optimized for use with Navio.
Company officials expect to expand Navio’s use to other surgical specialties, including neurosurgery, spinal and otolaryngology (ear, nose and throat).
Officials for the Minneapolis, Minn.-based firm, which makes “smart” surgical instruments for use in orthopedic surgery, reported the 1,000th partial knee replacement procedure has been performed using the company’s Navio surgical system. Navio is the firm’s principal technology. The system uses computer navigation and handheld robotic-assisted technology to provide accurate and precise bone preparation for unicondylar and patellofemoral knee replacement procedures.
The case was performed by Michael Higgins, M.D., orthopedic surgeon at Sentera CarePlex Hospital in Hampton, Va. “Navio has had tremendous success in the last two years”
“The precision, ease of use and predictability of outcomes that Navio’s robotic-assistance offers have made partial knee replacements a true pleasure to perform,” said Higgins.
After receiving CE mark for the Navio system in February 2012 and U.S. Food and Drug Administration (FDA) clearance in December 2012, Blue Belt initiated a full rollout in March 2013. In 2014, Blue Belt Technologies achieved several commercial milestones including selling 33 Navio systems, partnering with two major implant companies, and receiving FDA clearance for a patellofemoral joint replacement application.
“Navio has had tremendous success in the last two years,” said Eric Timko, president and CEO of Blue Belt Technologies. “Last August, Blue Belt announced our 500th case. Six months later we’ve seen our incredible growth continue. Our company remains committed to bringing truly innovative technology to our customers and fostering the growth that happens when we do.”
The Navio system provides robotic assistance for partial knee replacement procedures through proprietary computed tomography-free navigation software and a handheld, computer-controlled, bone-shaping tool. Navio supports six different knee systems. In addition, the company’s Stride unicondylar knee system provides implant features optimized for use with Navio.
Company officials expect to expand Navio’s use to other surgical specialties, including neurosurgery, spinal and otolaryngology (ear, nose and throat).